Monte Carlo dosimetry for 103Pd, 125I, and 131Cs ocular brachytherapy with various plaque models using an eye phantom

• Published in: Medical physics (Lancaster) 2014-03, Vol.41 (3), p.031706-n/a
• Main Authors: Lesperance, Marielle, Martinov, M., Thomson, R. M.
• Format: Article
• Language: English
• Subjects: BrachyDose; brachytherapy; Brachytherapy - methods; Cancer; Carbon; Cesium Radioisotopes - chemistry; Collimation; Computer Simulation; Cs‐131; dose calculations; dosimetry; Dosimetry/exposure assessment; EGSnrc; eye; Eye - diagnostic imaging; Eye Neoplasms - radiotherapy; eye plaques; Fluorescence; Gold; Humans; Iodine Radioisotopes - chemistry; I‐125; Monte Carlo; Monte Carlo Method; Monte Carlo methods; Numerical modeling; ocular brachytherapy; Palladium - chemistry; Pd‐103; phantoms; Phantoms, Imaging; Photons; physiological models; Probability theory, stochastic processes, and statistics; Radiation therapy; radioisotopes; Radioisotopes - chemistry; Radiometry - methods; Radionuclide Imaging; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Scintigraphy; Stainless Steel; Therapeutic applications, including brachytherapy; tumours; vision
• ISSN: 0094-2405; 2473-4209
• DOI: 10.1118/1.4864474

Purpose: To investigate dosimetry for ocular brachytherapy for a range of eye plaque models containing103Pd, 125I, or 131Cs seeds with model-based dose calculations. Methods: Five representative plaque models are developed based on a literature review and are compared to the standardized COMS plaque, including plaques consisting of a stainless steel backing and acrylic insert, and gold alloy backings with: short collimating lips and acrylic insert, no lips and silicone polymer insert, no lips and a thin acrylic layer, and individual collimating slots for each seed within the backing and no insert. Monte Carlo simulations are performed using the EGSnrc user-code BrachyDose for single and multiple seed configurations for the plaques in water and within an eye model (including nonwater media). Simulations under TG-43 assumptions are also performed, i.e., with the same seed configurations in water, neglecting interseed and plaque effects. Maximum and average doses to ocular structures as well as isodose contours are compared for simulations of each radionuclide within the plaque models. Results: The presence of the plaque affects the dose distribution substantially along the plaque axis for both single seed and multiseed simulations of each plaque design in water. Of all the plaque models, the COMS plaque generally has the largest effect on the dose distribution in water along the plaque axis. Differences between doses for single and multiple seed configurations vary between plaque models and radionuclides. Collimation is most substantial for the plaque with individual collimating slots. For plaques in the full eye model, average dose in the tumor region differs from those for the TG-43 simulations by up to 10% for125I and 131Cs, and up to 17% for 103Pd, and in the lens region by up to 29% for 125I, 34% for 103Pd, and 28% for 131Cs. For the same prescription dose to the tumor apex, the lowest doses to critical ocular structures are generally delivered with plaques containing 103Pd seeds. Conclusions: The combined effects of ocular and plaque media on dose are significant and vary with plaque model and radionuclide, suggesting the importance of model-based dose calculations employing accurate ocular and plaque media and geometries for eye plaque brachytherapy.